email article All inflammatory bowel disease (IBD) patients taking biologic treatment who received both doses of Pfizer-BioNTech or Moderna COVID-19 vaccines had a positive antibody response, a small prospective study showed. Of 48 IBD patients vaccinated in the study, all 41 who were on a biologic when they were vaccinated achieved seropositivity, Serre-Yu Wong, MD, PhD, of Icahn School of Medicine at Mount Sinai in New York City, and colleagues reported in Additionally, all 26 patients who completed the full two-dose vaccine schedule had a positive antibody response, while 84.6% of those achieved index levels that would qualify them for convalescent plasma donation. "This is an extremely promising finding for patients taking biologic medications for IBD," Wong noted in a press release. "To put it in context, we believe this is reassuring in light of two recent publications -- one in